Single intratumoral injection of long-acting benzyl ester of D-penicillamine inhibits the growth of melanoma tumor in mice

Milos Chvapil, Robert T Dorr

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Using a murine model of melanoma we tested the effect of D-penicillamine administered in repetitive, daily injections, or as a single large dose injected either in saline or in a biodegradable polymer. We also studied the effect of a single intratumoral injection of benzyl-ester-D-penicillamine on the growth of the tumor. Daily injections of the drug or its administration in a polymer or benzyl-ester of D-penicillamine were all significantly inhibitory. The inhibitory effect manifested 4-5 days after injection. The inhibition lasted 8-10 days. There was no evidence of local or systemic toxicity and no changes in body weight. Several possible mechanisms for the inhibitory effect are presented.

Original languageEnglish (US)
Pages (from-to)757-762
Number of pages6
JournalAnti-Cancer Drugs
Volume16
Issue number7
DOIs
StatePublished - Aug 2005

Fingerprint

Melanoma
Injections
Growth
Neoplasms
Polymers
Body Weight Changes
Penicillamine
penicillamine benzyl ester
Pharmaceutical Preparations

Keywords

  • Angiogenesis
  • Collagen structural stability
  • D-penicillamine
  • D-penicillamine benzyl ester
  • Lysyl oxidase
  • Matrix metalloproteinase
  • Melanoma
  • Murine model
  • Schiff base cross-links

ASJC Scopus subject areas

  • Pharmacology
  • Cancer Research
  • Oncology

Cite this

Single intratumoral injection of long-acting benzyl ester of D-penicillamine inhibits the growth of melanoma tumor in mice. / Chvapil, Milos; Dorr, Robert T.

In: Anti-Cancer Drugs, Vol. 16, No. 7, 08.2005, p. 757-762.

Research output: Contribution to journalArticle

@article{3d147e32e289461d902c7505d3620206,
title = "Single intratumoral injection of long-acting benzyl ester of D-penicillamine inhibits the growth of melanoma tumor in mice",
abstract = "Using a murine model of melanoma we tested the effect of D-penicillamine administered in repetitive, daily injections, or as a single large dose injected either in saline or in a biodegradable polymer. We also studied the effect of a single intratumoral injection of benzyl-ester-D-penicillamine on the growth of the tumor. Daily injections of the drug or its administration in a polymer or benzyl-ester of D-penicillamine were all significantly inhibitory. The inhibitory effect manifested 4-5 days after injection. The inhibition lasted 8-10 days. There was no evidence of local or systemic toxicity and no changes in body weight. Several possible mechanisms for the inhibitory effect are presented.",
keywords = "Angiogenesis, Collagen structural stability, D-penicillamine, D-penicillamine benzyl ester, Lysyl oxidase, Matrix metalloproteinase, Melanoma, Murine model, Schiff base cross-links",
author = "Milos Chvapil and Dorr, {Robert T}",
year = "2005",
month = "8",
doi = "10.1097/01.cad.0000171767.59187.c2",
language = "English (US)",
volume = "16",
pages = "757--762",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Single intratumoral injection of long-acting benzyl ester of D-penicillamine inhibits the growth of melanoma tumor in mice

AU - Chvapil, Milos

AU - Dorr, Robert T

PY - 2005/8

Y1 - 2005/8

N2 - Using a murine model of melanoma we tested the effect of D-penicillamine administered in repetitive, daily injections, or as a single large dose injected either in saline or in a biodegradable polymer. We also studied the effect of a single intratumoral injection of benzyl-ester-D-penicillamine on the growth of the tumor. Daily injections of the drug or its administration in a polymer or benzyl-ester of D-penicillamine were all significantly inhibitory. The inhibitory effect manifested 4-5 days after injection. The inhibition lasted 8-10 days. There was no evidence of local or systemic toxicity and no changes in body weight. Several possible mechanisms for the inhibitory effect are presented.

AB - Using a murine model of melanoma we tested the effect of D-penicillamine administered in repetitive, daily injections, or as a single large dose injected either in saline or in a biodegradable polymer. We also studied the effect of a single intratumoral injection of benzyl-ester-D-penicillamine on the growth of the tumor. Daily injections of the drug or its administration in a polymer or benzyl-ester of D-penicillamine were all significantly inhibitory. The inhibitory effect manifested 4-5 days after injection. The inhibition lasted 8-10 days. There was no evidence of local or systemic toxicity and no changes in body weight. Several possible mechanisms for the inhibitory effect are presented.

KW - Angiogenesis

KW - Collagen structural stability

KW - D-penicillamine

KW - D-penicillamine benzyl ester

KW - Lysyl oxidase

KW - Matrix metalloproteinase

KW - Melanoma

KW - Murine model

KW - Schiff base cross-links

UR - http://www.scopus.com/inward/record.url?scp=23344451977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23344451977&partnerID=8YFLogxK

U2 - 10.1097/01.cad.0000171767.59187.c2

DO - 10.1097/01.cad.0000171767.59187.c2

M3 - Article

C2 - 16027526

AN - SCOPUS:23344451977

VL - 16

SP - 757

EP - 762

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 7

ER -